On August 12 we launched a brand new website. Running on a professional platform and more flexible to update. This new version is also mobile ready, which means is easily readable on tablets and smartphones.
More content will be added in the coming days and weeks, we hope you enjoy it.
Please feel free to use the contact form for any remarks and/or suggestions.
We are delighted to announce that the European Prostate Awareness Day (EPAD) 2015 will take place in the European Parliament in Brussels on 16 September 2015, kindly hosted by Mr P. De Backer MEP. The event will be chaired by Mr De Backer MEP, Prof. C. Chapple, Secretary General of the European Association of Urology and Mr K. Mastris, Chairman of Europa Uomo. EPAD 2015 aims to raise awareness, understanding and knowledge of the management of prostate diseases in general and prostate cancer in particular, and their significant impact on the European male population.
The event brings together key policy makers, scientific experts, European associations working in the urological field and representatives of European patient groups with an interest in prostate disease. During this afternoon session several experts will elaborate what the impact is of living with benign prostatic enlargement and prostate cancer and how we can improve care and empower patients.
We hope you will be able to join the discussions! The invitation with the detailed agenda will follow.
For any questions or applications, please contact Anja Vancauwenbergh, Secretariat Europa Uomo, tel. +32 3 338 91 51, fax. +32 3 338 91 52, e-mail: email@example.com
Football’s loss was definitely urology’s gain when Per-Anders Abrahamsson gave up his aspirations to be a professional soccer player sand took up medicine. Per-Anders has been a collosus of urology. He stands tall, he walks even taller and he talks the talk.
The European School of Oncology is pleased to announce the 2nd edition of “ESO Prostate Cancer Observatory inoovation and care in the next 12 months”, which will be held during teh EAU15 Congress on March 20 in Madrid, chaired by Prof. H. van Poppel and Prof. R. Valdagni.
Discussion about the topic mentioned in the heading has been raised in a LinkedIn group called Beat Prostate Cancer. Simon Crompton, English health journalist, has also handled the same topic widely and to his credit including patient stories in an article in May-June issue of Cancer World.
In the beginning of his article he summarizes: “Every patient wants to be cured. But a culture that defines success as “cure” condemns many patients and doctors to failure. Should the cancer community be looking to broaden the concept of success to better reflect how well care plans deliver the best possible outcome tailored to each patient’s personal priorities?”
Are the ones seeing the topic from patient’s perspective left out from open discussion? Or is it seen as a medical question that only is a professional matter for doctors and researchers to speculate on? It is natural that treatments are thoroughly discussed between patient and doctor when planning and deciding about the treatment. The question however is whether the “silent thought” of cure being the only successful outcome in cancer care living in community gives justice to the patient. Or does it even compare to general treatment knowledge of today? From a broader perspective I think it is relevant to question if the persistent thought of relating cancer and death to each other is based on this same definition of successful outcome – cure.